Cardiovascular effects of 1-methyl-4-(1-naphthylvinyl)piperidine hydrochloride.

@article{Henderson1988CardiovascularEO,
  title={Cardiovascular effects of 1-methyl-4-(1-naphthylvinyl)piperidine hydrochloride.},
  author={T. R Henderson and E M DeLorme and K. Takahashi and Allan Poe Gray and K. L. Dretchen},
  journal={European journal of pharmacology},
  year={1988},
  volume={158 1-2},
  pages={
          149-52
        }
}
View on PubMed
doi.org
3 Citations

3 Citations

Citation Type

Citation Type

Inhibition of brain choline acetyltransferase in vivo: (E)-1-methyl-4-(1-naphthylvinyl)-1,2,3,6-tetrahydropyridine hydrochloride (B115), a depot form of a potent inhibitor.
Cardiovascular Analysis In Vivo
TLDR
Hemodynamic parameters are recorded continuously during the whole experiment and adrenaline and isoprenaline administration is repeated after injection of the highest dose of test compound to check for aor b-blocking activity.
54 – Calcium channel blocking agents in the management of acute anticholinesterase poisoning

References

SHOWING 1-5 OF 5 REFERENCES
Approaches to protection against nerve agent poisoning. (Naphthylvinyl)pyridine derivatives as potential antidotes.
TLDR
The most effective compound in slowing the rate of aging, (E)-4-[(4-methoxy-1-naphthyl)vinyl]pyridine methochloride (6), did not provide significant protection against soman in the mouse, and was apparently not related to CAT inhibition.
Protection by phenytoin and calcium channel blocking agents against the toxicity of diisopropylfluorophosphate.
Enhancement of depolarization-induced synaptosomal calcium uptake and neurotransmitter release by Bay K8644.
Protein measurement with the Folin phenol reagent.
The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.